$39 for q3 - not bad, considering, page-12

the market is fading no doubt about that (no one is putting a positive spin out there - just look at the price chart!) - the question is the rate at which it is fading... and as you point out Q on Q comps should be done on corresponding periods, but only -5.8% is not the worst result in the world... how long these numbers last is anyone's guess - but so long as they are selling , ACR is making money to fund its generic program... as to the future value of that (hopes and dreams) portfolio - that is open to debate